Abdominopelvic radiaton for stage I-II ovarian cancer The effect of grade on outcome

S. Hart; G. Ben-Baruch; E. Herczeg; A. Hertzberg; M. Modan; J. Menczer

Abdominopelvic radiaton for stage I-II ovarian cancer The effect of grade on outcome

S. Hart, G. Ben-Baruch, E. Herczeg, A. Hertzberg, M. Modan, J. Menczer

Clinical Departments

Tel Aviv University

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The initial postoperative treatment of 31 patients with stage I-II ovarian cancer of epithelial origin, consisted of abdominopelvic radiotherapy. The 5-year survival was significantly better in stage I as compared to stage II (81.1% vs 36.3%). There was a consistent trend in both stages for better outcome in grades 1-2. This trend, however, reached statistical significance only for PFI. Most of the patients with recurrent disease had grade 3 tumors. While satisfactory treatment results may be achieved with postoperative radiotherapy for stage I-II tumors which are well or moderately differentiated, it is not recommended for undifferentiated tumors.

Original language	English
Pages (from-to)	416-420
Number of pages	5
Journal	European Journal of Gynaecological Oncology
Volume	10
Issue number	6
State	Published - 1989

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{17251c4ca1514144991bc5a5195f07ab,

title = "Abdominopelvic radiaton for stage I-II ovarian cancer The effect of grade on outcome",

abstract = "The initial postoperative treatment of 31 patients with stage I-II ovarian cancer of epithelial origin, consisted of abdominopelvic radiotherapy. The 5-year survival was significantly better in stage I as compared to stage II (81.1% vs 36.3%). There was a consistent trend in both stages for better outcome in grades 1-2. This trend, however, reached statistical significance only for PFI. Most of the patients with recurrent disease had grade 3 tumors. While satisfactory treatment results may be achieved with postoperative radiotherapy for stage I-II tumors which are well or moderately differentiated, it is not recommended for undifferentiated tumors.",

author = "S. Hart and G. Ben-Baruch and E. Herczeg and A. Hertzberg and M. Modan and J. Menczer",

year = "1989",

language = "אנגלית",

volume = "10",

pages = "416--420",

journal = "European Journal of Gynaecological Oncology",

issn = "0392-2936",

publisher = "S.O.G. CANADA Inc.",

number = "6",

}

TY - JOUR

T1 - Abdominopelvic radiaton for stage I-II ovarian cancer The effect of grade on outcome

AU - Hart, S.

AU - Ben-Baruch, G.

AU - Herczeg, E.

AU - Hertzberg, A.

AU - Modan, M.

AU - Menczer, J.

PY - 1989

Y1 - 1989

N2 - The initial postoperative treatment of 31 patients with stage I-II ovarian cancer of epithelial origin, consisted of abdominopelvic radiotherapy. The 5-year survival was significantly better in stage I as compared to stage II (81.1% vs 36.3%). There was a consistent trend in both stages for better outcome in grades 1-2. This trend, however, reached statistical significance only for PFI. Most of the patients with recurrent disease had grade 3 tumors. While satisfactory treatment results may be achieved with postoperative radiotherapy for stage I-II tumors which are well or moderately differentiated, it is not recommended for undifferentiated tumors.

AB - The initial postoperative treatment of 31 patients with stage I-II ovarian cancer of epithelial origin, consisted of abdominopelvic radiotherapy. The 5-year survival was significantly better in stage I as compared to stage II (81.1% vs 36.3%). There was a consistent trend in both stages for better outcome in grades 1-2. This trend, however, reached statistical significance only for PFI. Most of the patients with recurrent disease had grade 3 tumors. While satisfactory treatment results may be achieved with postoperative radiotherapy for stage I-II tumors which are well or moderately differentiated, it is not recommended for undifferentiated tumors.

UR - http://www.scopus.com/inward/record.url?scp=0024854907&partnerID=8YFLogxK

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???

AN - SCOPUS:0024854907

SN - 0392-2936

VL - 10

SP - 416

EP - 420

JO - European Journal of Gynaecological Oncology

JF - European Journal of Gynaecological Oncology

IS - 6

ER -

Abdominopelvic radiaton for stage I-II ovarian cancer The effect of grade on outcome

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this